We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genedata Provides Expressionist Platform to U.S. Food and Drug Administration
News

Genedata Provides Expressionist Platform to U.S. Food and Drug Administration

Genedata Provides Expressionist Platform to U.S. Food and Drug Administration
News

Genedata Provides Expressionist Platform to U.S. Food and Drug Administration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genedata Provides Expressionist Platform to U.S. Food and Drug Administration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata has announced an agreement with the National Center for Toxicological Research of the U.S. Food and Drug Administration for the company’s Genedata Expressionist® biomarker discovery platform.

Genedata Expressionist is a modular computational platform for biomarker discovery that integrates transcriptomics, proteomics and metabolomics data within a single enterprise software system.

With sophisticated high-throughput data processing and automated workflows for quality assessment, statistical analysis and interpretation functionalities, the platform provides a single-point-of-access for all experimental data, including sample information, raw and pre-processed data, analysis results and documentation with reports.

Weida Tong, Director of the Center for Toxicoinformatics at the U.S. Food and Drug Administration (FDA), said, “Given the vast quantities and varied sources of microarray data for the voluntary genomics data submission (VGDS) program, it is vital that my team have the most effective set of tools available to assay the data quality of submitted results.

The automated quality assurance tools available in Expressionist will enable us to ensure reproducible and reliable results and to provide quantitative feedback where data quality is in question.”

Dr. Jens Hoefkens, Managing Director of Genedata, said, “We are delighted that the FDA has chosen Expressionist to ensure that reviewers of our customers` data at the FDA can use the same suite of tools and applications to identify markers based on rigorous quality control standards.”

Advertisement